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Introduction
 
Nucleic acids are not immunogenic by themselves unlike proteins and carbohydrates.
In practice antibodies are raised against nucleic acids and their components using them
as haptens in combination with proteins. Nucleic acid reactive antibodies are present in
the sera of human-beings and animals affected with certain autoimmune disorders.
Currently monoclonal antibodies are also being raised against nucleic acids.
Nucleic acid reactive antibodies are of great interest in clinical medicine, cell biology
and molecular biology. They are used as markers to detect certain autoimmune
diseases. Nucleic acid reactive antibodies of definite specificities find wide applications
in the detection, estimation and isolation of specific nucleic acids and nucleic acid
components. They are used as reagents to locate modifications or conformational
variations in nucleic acid polymers even when they occur in combination with other
macromolecules like proteins. They have good potential as inhibitors of nucleic acid
functions. Their use as anticancer agents has been proposed (Senapathy and Jacob,
1979). 
Nucleic acid immunology has been reviewed previously (Plescia and Braun, 1967;
Lacour et al., 1973; Stollar, 1973, 1975, 1980; Munns and Liszewski, 1980; Erlanger,
1980; Lee 1984). The present review attempts to focus on the specificities and the
consequent applications of nucleic acid reactive antibodies in cell biology and
molecular biology.
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Nucleic acid reactive autoantibodies
 
Nucleic acid reactive autoantibodies are present in the serum of individuals affected
with systemic lupus erythematosus (SLE), a disease of the immune system (Koffler,
1980). They generally belong to IgG or IgM class (Ross et al., 1978). Some of these
antibodies react with single-stranded DNA (ssDNA), and/or double-stranded DNA 
(dsDNA), Z-DNA, tRNA, rRNA and nucleoproteins like snRNP.
The bases are recognised by ssDNA binding antibodies and cover 5–6 bases (Stollar 
1981). The antibodies that bind to dsDNA recognises to a large extent the sugar- 
phosphate backbone and covers only two or three base pairs. The antibodies that bind
to both ssDNA and dsDNA may be recognising mainly the backbone of one DNA
strand. 
Anti DNA antibodies have been purified on hydroxyapatite column (Fishbein et al., 
1980). Different populations of antibodies have been separated by passing the serum 
successively through ss-poly dT-Sepharose and T5-dsDNA-Sepharose columns
(Gillian et al.,1980). Some fractions of dsDNA binding antibodies distinguish between
ds-poly [d(AT)] and pBR 322 DNA. The importance of DNA structure in antibody
recognition has been demonstrated by competition experiments on the binding of
antibodies to [3H]-dsDNA from colicin El plasmids (Casperson and Voss, 1983).
The presence of two distinct populations of antinucleic acid antibodies—one
recognising polyribonucleotides and the other polydeoxyribonucleotides have been
demonstrated (Eilat et al., 1978). Antibodies specific for rRNA (Eilat et al., 1980) and
another for tRNA (Eilat et al., 1977) were detected in a strain of autoimmune mice. The
tRNA binding antibodies showed a definite preference for native tRNA as compared to
tRNA denatured and crosslinked with formaldehyde.
One other notable group of autoantibodies are those against small nuclear
ribonucleoproteins (snRNPs). snRNPs consist of a variety of small stable RNAs
complexed with proteins. The interaction of these RNPs with antibodies and their 
application in studying and classifying these RNPs have been discussed (Lerner and 
Steitz 1979) and reviewed (Lerner and Steitz, 1981). It has been demonstrated that both
the RNA and the protein in the RNP complex are equally important in antigenicity
(Mattiöli and Reichlin 1971; Dơuvas et al., 1979). Direct evidence for the involvement
of snRNAs in the splicing of adenovirus RNA was obtained using snRNA antibodies 
(Yang et al., 1981)
With a view to identify the specific antigenic determinants which the SLE antibodies 
recognise, monoclonal antibodies have been raised from both mouse and human
systems (reviewed by Eilat, 1982). Antibodies with some sequence preferences were
obtained (Lee et al., 1981); for example, one monoclonal antibody bound to d(TTC)n 
but not to d(TCC)n, while another interacted strongly with d(TG)n. d(CA)n but not 
with d(TC)n. d(GA)n. In some cases the monoclonal antibodies cross reacted with a 
wide variety of polynucleotides and phospholipids like cardiolipin, phosphatidic acid 
and phosphatidyl glycerol (Lafer et al., 1981a). Another monoclonal anti-DNA
antibody has been observed to bind to cell surface proteins as detected by cell-binding 
experiments (Jacob et al., 1984).
The idiotypic features of anti-DNA antibodies have been studied using polyclonal
(Andrezejewski et al., 1981; Datta et al., 1983) and monoclonal (Solomon et al., 1983)
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antiidiotype antibodies. It was found that antiidiotype antibodies cross-reacted with 
antibodies from different clones, suggesting that although anti-DNA antibodies are 
produced by different clones, they have similar antigen binding regions. These 
antiidiotype antibodies in some cases cross-reacted with antibodies from different 
individuals. As this indicates that autoantibodies are derived from related families of 
germlines, cross-reactivities are not surprising. 
 
 
Antibodies elicited against nucleic acid haptens 
 
Nucleic acids or their components are either electrostatically complexed with basic 
proteins like methylated bovine serum albumin or chemically coupled to proteins like 
bovine serum albumin to make them immunogenic. The most widely used methods for 
chemical coupling are the periodate oxidation method (Erlanger and Beiser, 1964) and 
the carbodiimide method (Halloran and Parker, 1966). The periodate oxidation
method involves the oxidation of the ribose moiety and subsequent formation of a 
Schiff's base linkage with the aminogroups of proteins. Finally the linkage is stabilized
by reduction with sodium borohydride. The carbodiimide method involves the
condensation of phosphate moiety of nucleotides to the amino groups of proteins.
 
Antibodies specific to nucleosides and modified nucleosides
 
In most of the studies on antibodies to normal and modified ribonucleosides, protein- 
nucleoside conjugates prepared by the periodate method were used as immunogens. In 
this method the structure of ribose attached to proteins is altered. The antibodies 
induced show specificity for the ribose ring-opened trialcohol form than the parent 
nucleoside structure. Some of them react better with respective deoxynucleoside than 
the ribonucleoside. These antibodies have been used for radioimmunoassays (Schrader 
et al., 1978; Hughes et al., 1973). They bind to both RNA and ssDNA. In the case of 
adenosine antibodies, the populations that bind to RNA were found specific to
morpholine derivative of adenine (Raju, 1984).
A wide spectrum of modified nucleosides like methylated nucleosides, carcinogen
modified nucleosides, ultra-violet (UV)-induced photoproducts, isopentenyl aden-
osine, wyosine, queosine etc., give highly specific antibodies (reviewed by Munns and 
Liszewski, 1980) and have found wide applications. For example, tRNAArg containing 
inosine were isolated using antibodies against inosine (Inouye et al., 1973).
Isopentenyl adenosine (i6A) is of great interest among the modified nucleosides as it
is a plant hormone, stimulating cell division and differentiation in plant systems. It is 
also a component of tRNAs of numerous organisms. Antibodies to i6A (Hacker et al., 
1972; Humayun and Jacob 1974a,b; Jayabaskaran and Jacob, 1983) are produced in 
very high titres in rabbits (Humayun and Jacob, 1974c) and have been used for 
radioimmunoassay (Shivkumar et al., 1976; Khan et al., 1977a) and isolation of i6A, 
i06A and cytokinin containing tRNAs (Senapathy and Jacob, 1981; Jayabaskaran and 
Jacob 1982) and tRNA precursors (Jayabaskaran, 1984). 
Antibodies to m7G have been used to isolate mRNAs which have a m7G containing 
5' cap (Meredith and Erlanger, 1979) and m7G antibodies inhibited in vitro translation 
of chorion mRNA in a wheatgerm system (Munns et al., 1979). m 62 A antibodies were
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used as a probe to pinpoint the location of 16S rRNA by immunoelectronmicroscopy in 
the 30S ribosomal subunit (Politz and Glitz, 1977). Similarly the position of m6A in
bacteriophage fd DNA was located (Munns and Liszewski, 1980).
Modified bases in DNA are of great interest as the methylated bases, especially m5C 
play a role in gene regulation. Availability of specific antibodies have made it possible to
detect and quantitate even picomole amounts of m5C. Recently m6A and m7G have 
been detected and estimated in eukaryotic DNAs using respective antibodies (Achwal 
and Chandra, 1982; Achwal et al., 1983, 1984).
Immunoprecipitatable DNA probes ('immunonucleic probes') are of use in con-
structing genetic linkage maps of large genomes. Such probes have been prepared by
modifying the probe DNA with N-acetoxy-N2-acetylaminofluorene (AAF) or iodi- 
nated AAF both of which modify G in DNA. The probe hybridizes with large genomic 
fragments and also gets precipitated by antibodies raised against guanosine-AAF or 
DNA-AAF (Tchen et al., 1984). 
Most chemical carcinogens, cancer-therapeutic drugs, ionizing radiation and UV
light cause structural modifications in DNA. Antibodies with high affinity to modified 
deoxyribonucleosides are of great value in detecting and quantitating these modify-
cations (reviewed by Adamkiewicz et al., 1984a). Examples are O6 butyl de- 
oxyguanosine, O4 butyl deoxythymidine (Saffhill et al., 1982), O6 ethyl 2'-deoxy 
guanosine and O4 ethyl thymidine riboside (Rajewsky et al., 1983, Adamkiewicz et al., 
1984b). They have been used to study the modifications caused by alkylating 
carcinogens on DNA and subsequent repair. 
Antibodies have been raised against DNA modified by UV light, X-rays and
chemicals. As the modified bases are immunodominant, the antibodies elicited are 
usually specific to modified nucleosides and other features of the polymer. In case of 
exposure to UV light, the antibodies are specific for the pyrimidine dimers formed, and 
also the altered conformational structure associated with these lesions (Wakizaka and 
Okuhara, 1979). The amount of thymidine dimers formed as well as the repair have
been quantitated using antibodies raised against UV exposed calf-thymus DNA 
(Seaman et al., 1972). One monoclonal antibody raised against UV-ssDNA recognises 
thymidine dimers in a polynucleotide fragment longer than tetranucleotide, but not 
isolated thymidine dimers suggesting that the adjacent sequences are also important for
antibody binding (Strickland and Boyle, 1981). The binding sites of AAF on Col E1
DNA has been located using AAF-DNA antibodies (Murcia et al., 1979).
Fuchs et al., (1974) raised antibodies to gluteraldehyde conjugated tRNAphe and
found that the antibodies are primarily directed towards the highly modified nucleoside 
Υ and not to the tRNA itself.
 
 
Antibodies to mononucleotides
 
Antibodies raised against ribonucleotides by the periodate method do not discriminate 
between DNA and RNA even though they are base specific. Antibodies raised against 
pG by the carbodiimide method bound to RNA at pG residues but not to DNA (Iswari, 
1981). pA antibodies were specific for the whole molecule and had very low cross 
reactivity with pG, pC and pU (Ali, 1981).
Antibodies raised against dpA (Humayun and Jacob, 1973) dpG (Jayaraman and
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Jacob, 1980a) dpC (Reddy and Jacob, 1983a) dpT (Chandrasekharappa, 1981) and
dpm5C (Reddy, 1980) show very high specificity to the respective hapten when tested by 
radioligand binding and competition experiments. For example dpA antibodies
showed a high degree of discrimination among the four deoxyribomononucleotides by 
a minimum factor of 8000. It had a high degree of specificity for the whole structure of
the nucleotide. The nucleoside, base, or sugar phosphate were poor inhibitors of dpA 
binding. Blocking of the 3’OΗ group of dpA by acetylation resulted in 10 fold decreased 
affinity for the antibody sites. The immunodominance of 2 and 6 positions of adenine 
moiety is evident from a comparison of the inhibition by dpA, dpG and dpT. The 
binding of dpA antibodies to [3H]-dpA could not be inhibited by native DNA.
Denatured DNA showed inhibition only at very high concentrations indicating low 
affinity. Affinity of mononucleotide antibodies to oligonucleotides have been studied 
by inhibition analysis of mononucleotide binding. They prefer oligonucleotides with
the respective hapten residues at the 3' end. For example dpG antibodies have thousand 
fold less affinity to dpGpA compared to dpApG or other oligonucleotides with dpG at
the 3' end. 2, 6 and 8 positions of guanine seem to be important in antibody recognition.
Some of the nucleotide antibodies can distinguish well between respective deoxy and
ribonucleotides. For example dpC antibodies (Reddy and Jacob, 1981a) show 1400 fold 
more affinity to dpC compared to pC and can distinguish between DNA and RNA
(Reddy and Jacob, 198 1b) and bind to denatured DNA at dpC residues. dpC antibodies
unexpectedly showed higher affinity to dpm5C than dpC (Reddy, 1980).
Antibodies raised against nucleotides are heterogenous and there are populations of 
antibodies which bind to dsDNA with base specificity. This has been demonstrated in 
the case of dpG and dpC antisera (Jacob and Jacob, 1982). dsDNA binding dpG 
antibodies have been purified and their interaction with dsDNA and human 
metaphase chromosomes studied (Jacob, 1984). The interactions are base specific. The
staining of chromosomes by indirect immunoperoxidase method using dpG antibodies 
showed differences in staining intensities between chromosomes in a pair and between
chromatids in a chromosome. As the staining is dpG specific, it is expected that the
differences in staining are due to differences in content or environment of dpG residues
in the presumably identical chromatids.
 
Antibodies to oligonucleotides
 
With a view to obtain antibodies specific to nucleotide sequences, antibodies have been 
raised against oligonucleotides chemically coupled to proteins or electrostatistically 
complexed with methylated borine serum albumin (MBSA). 
Antibodies to ApC, CpA, CpU and UpA recognised both component bases and the 
nucleoside attached to the carrier protein seemed to be immunodominant (Beiser and 
Erlanger, 1966; Estrada-Parra and Garcia-Ortigoza, 1972). Antibodies against ApApC, 
ApUpG and ApApU showed reactivity with the respective hapten (D’Alisa and 
Erlanger, 1974; Bonavida et al., 1972). 
Antibodies to MBSA complexes of ApApCp, ApApUp, ApGpCp, ApGpUp,
GpUpUp and ApUpGp showed some degree of specificity to the respective hapten 
sequences, but in some cases the specificity appeared to be to the sugarphosphate
backbone (Plescia et al., 1968).
Antibodies raised against deoxyribo di- and tri-nucleotide haptens by the car-
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bodiimide method have shown good sequence specificity. In the case of dpApT
antibodies, dpApT was the best inhibitor of binding to 3H-dpApT where as the reverse
sequence dpTpA was required in more than 2000 fold concentration to bring about
equivalent inhibition. The antibodies were formed against the whole molecule, as
dApT, dpA and dpT were bad inhibitors. The higher inhibitory capacity of dpT 
compared to dpA showed that the nucleotide at the 3' end of the hapten is 
immunodominant. The antibodies show good affinity to oligonucleotides having 
dpApT at the 3' end (Khan et al., 1977b). dpApT antibodies purified on AH-Sepharose- 
dpApT column bound to denatured colitis phage DNA at dpApT sequences as shown 
by inhibition studies (Reddy and Jacob, 1983b). Certain populations of dpApT
antibodies are bound to dsDNA (Jacob and Jacob, 1982) and they are likely to be
specific to a particular conformation of dpApT. Antibodies raised against the
dinucleotide dpTpA also showed good sequence specificity (Chandrasekharappa, 1981; 
Gopalakrishnan, 1976). Antibodies raised against the deoxytrinucleotides dpApTpA 
and dpApApT showed good specificity to the respective haptens (Khan and Jacob, 
1977). From studies on the trinucleotide hapten coupled to protein through 5' 
phosphate or 3' phosphate it seems that the immunodominant part of the oligonuc- 
leotide is the one farthest away from the point of coupling to the protein (Jayaraman 
and Jacob, 1980b).
 
Antibodies to double stranded and triple stranded polynucleotides
 
Antibodies have been raised against MBSA complexes of double stranded and triple
stranded polynucleotides (reviewed by Lacour et al., 1973; Stollar 1975). The method 
used to form the ds or ts helices was to mix the complementary homopolymers in 
optimum proportions. Antibodies against these polynucleotides seem to be specific
mainly for the sugar phosphate backbones.
Antibodies raised against poly (A). poly (U) have been found to react well with poly (I).
poly(C) or viral dsRNAs (Raso and Schreiber, 1978). Purified poly(I)·poly(brC)
antibodies react well with several ds-polyribonucleotides such as poly (A) poly(U),
poly(I)·poly(brC), but not poly(G) poly(C), poly(X) ·poly(U) or DNA (Guiges and
Leng, 1976). Antibodies to ds ribonucleotides have been used to detect the presence of
dsRNA in a variety of cells infected with Sindibis virus (Stollar and Stollar, 1970; Stollar 
et al., 1972), Reovirus (Silverstein and Schur, 1970) as well as uninfected cells (Stollar et
al., 1978). 
Antibodies specific for triple stranded polynucleotides clearly distinguish ts
and ds structures. Examples are antibodies to poly(U)·poly(A)-poly(U),
poly(U)·(dA)·poly(U), poly(U)·poly(A)·poly(I) (Rainen and Stollar, 1978a; Nahon- 
Merlin et al., 1971; Papallian et al., 1980). Antibodies to poly (A)·poly (U)·poly (I) have 
been fractionated into three antibody populations, each recognising a different
conformational feature of the triple helical immunogen (Rainen and Stollar, 1978b).
Antibodies distinguish helices built on poly (A) from that built on poly (dA) (Stollar and
Raso, 1974).
 
Antibodies to RNA-DNA hybrids
 
Antibodies raised against poly (A)·poly (dT) have been shown to react with
poly (I)·poly (dC) and also natural RNA-DNA hybrids (Rudkin and Stollar, 1977).
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Antibodies to φ × 174 DNA-RNA hybrids have been shown to be specific to naturally
occurring DNA·RNA hybrids and they did not bind to synthetic hybrid homopo-
lymers like poly·(A) poly (dT) (Nakazato, 1979). It has been shown that
poly (A)·poly (dT) is a better immunogen than poly (I) poly (dC) in eliciting antibodies 
to RNA·DNA hybrids (Kitagawa et al., 1982). This may be because poly (A)·poly (dT) 
forms a more stable helix than poly (I)·poly (dC). 
Antibodies against poly (A)·poly (dT) were used to detect DNA·RNA hybrids in
polytene chromosomes of Drosophila (Rudkin et al., 1977). Using the antibodies the
regions carrying 5S rRNA genes on the chromosomes were located after hybridizing
with 5S rRNA. Similarly antibodies to poly (A) poly (dT) were coupled to Sepharose 
and was used to enrich and isolate rDNA of Dictyostelium (Stumph et al., 1978). The
DNA was found to contain sequences coding for 17S and 26S rRNAs and adjacent
regions. Regions of active transcription on the polytene chromosomes of Trichosia were
pinpointed using antibodies (Busen et al., 1982).
 
Antibodies to Z-DNA
 
Z-DNA is a left handed double helical form of DNA which was characterized by X-ray 
crystallographic studies on hexanucleotide CpGpCpGpCpG (Wang et al., 1979). In Z-
DNA was found to contain sequences coding for 17S and 26S rRNAs and adjacent 
syn conformation. Alternating purine-pyrimidine sequences other than AT attain Z- 
conformation at high salt concentrations. Chemical modifications like bromination, 
methylation or iodination of poly d(GC) make it attain Z-form under physiological
ionic conditions. Z-DNA gives characteristic circular dichorism (CD), Raman and 
[31P]-NMR spectra distinct from that of B-DNA. Immunological studies on Z-DNA
have been reviewed (Rich et al., 1983, 1984; Lafer et al., 1983a; Leng et al., 1983).
Z-DNA antibodies have been found to occur in sera of certain autoimmune mice
(Lafer et al., 1981b), SLE patients (Lafer et al., 1983b), patients affected with Crohn’s
disease, polyradiculoneuritis, and amylotrophic lateral sclerosis (Allinquaint et al.,
1984). Antibodies to Z-DNA form a valuable probe for identifying and localizing Z-
DNA in different systems. Such identification using antibodies is more reliable than
physical techniques that rely on changes in physical properties that are consistent with
Z-DNA, but not necessarily restricted to Z-DNA (Tomasz et al., 1983).
Polynucleotides in Z-form are complexed with MBSA to elicit antibodies in rabbits 
or mice. Brominated poly[d(GC)] (Lafer et al., 1981b), poly[d(GC)] modified on N7 of
guanosine with chlorodiethylene triaminoplatinum (dien-Pt) (Malfoy and Leng 1981) 
poly[d(Gs-C)] in which phosphorothioate group is present instead of phosphate 
group, poly[d(G-x/y/zC) ] in which the 5 position of cytosine is methylated, brominated 
or iodinated, were found to be immunogenic (Zarling et al., 1984). DNAs incapable of
assuming left-handed conformation under physiological salt conditions were weakly or
non-immunogenic. These include unmodified poly[d(GC)] as well as poly[(d(AC)].
poly[d(GT)] family of sequences bearing pyrimidine C-5 substitutions. Z-DNA
reactive antibodies were obtained against poly[d(GC)] modified with cis-diamine
dichloroplatium even though this polymer is not either in B- or Z-forms under
physiological ionic conditions as seen from CD and [31P]-NMR studies (Malinge et
al., 1984). 
The Z-DNA antibodies are specific for the left-handed DNA conformation, with
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characteristic binding preferences indicative of structural variations in Z-DNA itself. 
The structural features recognised include the sugar phosphate backbone, convex 
surface and minor grove. Antibodies raised against br-poly[d(GC)] bound to Z- [3H]- 
br poly[d(GC)]. The binding was inhibited by br-poly [d(GC)] but not by
poly[d(GC)], br-poly (dG), poly(dG), br poly (dG). poly (dC) or denatured calf thymus
DNA, baby hamster kidney RNA or poly (A). poly (dT). Studies on the precipitation of
[3H]-poly[d(GC)] by poly[d(GC)]-dien-pt antibodies as a function of NaCl concen- 
tration, showed that there was a sudden increase in precipitation at 1.2 Μ NaCl which
correlated well with the formation of Z-DNA (Malfoy and Leng, 1981). Lack of
interaction of these antibodies to Z-poly[d(I.br5C)] suggest that the aminogroup of
guanine is important for antibody binding. From quantitative precipitin curves it has 
been estimated that the antibody binding site covers 3-5 nucleotides (Malfoy et al.,
1982). Poly[d(A·xC)] poly[d(G·yT)] and poly[d(G·zC)] families of Z-DNA display
common as well as distinct antigenic determinants (x, y · z indicate methyl, bromo or
iodo substitutions). Antibodies elicited against Z-br poly[d(GC)] bound to both Z-
poly[d(GC)] and Z-poly[d(AC)] · poly[d(GT)] in high salt RIA (Zarling et al., 1984).
Unmodified Z-poly[d(GC)] was recognised by all Z-DNA antibodies tested. The 
binding sites recognised by anti poly[d(G· br5C)] are different from those recognised 
by br-poly[d(GC)] antibodies. The cytidine 5 position appeared to be important not 
only for stabilization of left handed conformations as already stated but also serves as a 
major site of antibody recognition. 
In the case of monoclonal antibodies raised against Z-br-poly[d(GC)] (Moller et al.,
1982), one bound to Z-poly[d(G · m5C)] but another did not though both bound to Z-
poly[d(GC)]. Two monoclonal antibodies raised against Z-br poly[d(GC)] were
studied by Zarling et al. (1984). Both bound Z-poly[d(GC)], Z-br poly [d(GC)] and Z-
poly[d(G s− C)] but not Z-poly[d(A·m5C)]-poly[d(G·T)]. It appears that a bromine or
methyl group at the 5-position of the pyrimidine can block the antibody binding site,
which is likely to be on the convex surface of DNA.
 
 
Binding of anti Z-DNA antibodies to plasmid and viral DNAs
 
It has been demonstrated by electrophoresis that Z-DNA structure is induced by 
negative supercoiling in recombinant plasmids containing poly[d(GC)] inserts, under 
physiological ionic conditions (Singleton et al., 1982). Nordheim et al. (1982) were able 
to demonstrate that Z-DNA antibodies bound to two recombinant plasmids, one
containing 32 and the other 14 GC repeats. Using ethidium bromide and topoisom- 
erase, plasmids with different degrees of supercoiling were generated. It was found that 
the plasmid with the longer insert bound to the antibodies at a lower degree of 
supercoiling. Bound antibodies were cross-linked to the plasmids and then cut with 
restriction enzymes. The antibody bound fragments were trapped on nitrocellulose 
filter and the filterate was analysed. It was seen that the binding of the antibodies was to 
the (GC)n insert. Surprisingly pBR322 also showed binding to the antibodies, the 
sequence bound being CACGGGTGCGCATG. It should be mentioned that all
plasmids formed Z-DNA at physiological degrees of supercoiling itself. Studies on 
plasmids containing inserts of d (CA)32 · d (G T)32 also gave similar results (Nordheim 
and Rich, 1983a). Studies on SV40 genome showed that Z-DNA is present in 
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transcriptional enhancer regions. Three regions which formed Z-DNA are at map
locations 258-265, 199-205 and 128-133, the sequences being ATGTGTGT,
GCATGCAT and GCATGCAT respectively (Nordheim and Rich, 1983b).
Zarling et al., (1984) studied the binding of different Z-DNA antibodies to pBR322 
and SV40 DNAs by agarose electrophoresis. It was found that these antibodies bound 
only to supercoiled DNA and occasionally crosslinked the DNA.
Pohl et al. (1982) observed that both monoclonal and polyclonal antibodies bound to
Form V DNA which is formed by the annealing of complementary circular ssDNA.
This DNA has a linking number of zero. The CD spectrum of Form V DNA had
indicated the presence of left handed sequences. 
Thomae et al. (1983) were able to isolate Z-DNA containing plasmids from
Escherichia coli using purified monoclonal Z-DNA antibodies coupled to Sephacryl S-
1000. From the amount of DNA bound, it seems that 1 % of the plasmids contain Z-
DNA. 
 
Binding anti-Z-DNA antibodies to eukaryotic chromosomes
 
The presence of Z-DNA in eukaryotic chromosomes was checked by different groups
of workers using Z-DNA antibodies. Nordheim et al., (1981) demonstrated by indirect 
immunofluorescence that Z-DNA antibodies bound to fixed polytene chromosomes of 
Drosophila. The binding was restricted only to the interband regions and the intensity 
varied among different interbands in a reproducible manner. The binding could be
inhibited by Z-DNA but not B-DNA. Lemeuneier et al. (1982) did similar experiments 
on polytene chromosomes of Chironomus but found that the binding was mainly in the
band regions. Detailed studies were done by Arndt-Jovin et al. (1983) using antibodies
against Z-br-poly[d(GC)], Z-poly[d(Gm5C)] and Z-poly[d(G5-C)]. They were found 
to bind to both Drosophila and Chironomus chromosomes and the binding was mainly
in the band regions. It was calculated that approximately 0·02 to 0·1 % of DNA is in Ζ
form. The presence of Z-DNA in the nucleus of the ciliate protozoan Stylonichia
mytilus during different stages of life cycle was studied by Lipps et al. (1983) using anti
Z-br poly[d(GC)] antibodies. In the vegetative cells the Z-DNA antibodies bound only
to the macronucleus but not to the micronucleus, but an anti-B-DNA antibody bound
both equally well. In the life cycle, no binding was seen at the polytene chromosome
stage, but there was binding after the DNA elimination stage.
In vetebrates, Morgenegg et al. (1983) has shown by immunohistochemical
techniques that anti Z-DNA antibodies bind to nuclei of various rat tissues, but 
differentially. Studies on Z-DNA immunoreactivity of fixed metaphase chromosomes 
of man and a primate Cebus albifrons (Viegas-Pequignot et al., 1983) showed different
levels of staning. In Cebus, intense staining was located in the R-Band positive
heterochromatin segments. In contrast the human karyotype did not show any binding
to R and positive heterochromatin segments.
All the chromosome studies discussed above involved the classical method of fixing 
chromosomes in 45 % acetic acid. Hill and Stollar (1983) were able to show that Z-DNA 
antibody binding can be induced in chromosomes by fixing in 45 % acetic acid. 
Polytene chromosomes isolated in native state by microsurgical procedures without
acid fixation did not bind Z-DNA antibodies. But the same chromosomes after acid
fixation showed intense binding. If the chromosomes were exposed to 45 % acetic acid
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for 5 sec, returned to neutral pH and treated with antibody, the binding was found to be 
in the interbands and puffs. But if the treatment was prolonged for 25 sec, there was a 
great increase in the binding, and it was predominantly in the band regions. This
explains the discrepancy in earlier reports that in some cases the binding being to bands 
and in others interbands. It appears that acid treatment induces Z-DNA formation in
some parts of chromosomal DNA.
Exposure to 45 % acetic acid can extract four core histones of nucleosomes which can
induct negative supercoils into chromosomal DNA. This may cause Β → Ζ transition.
The possibility of this mechanism was established by studies using DNase I and
Topoisomerase I. 
Z.DNA appears to be of wide spread occurrence, existing as isolated or multiple sites
in both prokaryotic and eukaryotic genomes under certain conditions and upon
stabilization with specific ligands. It is possible that different Z-DNA structures and
sequences have both common and unique functions (Zarling et al., 1984).
 
 
Conclusion 
 
Nucleic acid reactive antibodies have proved to be valuable tools for the radioim-
munoassays of nucleic acid components, for the detection of modifications on DNA
and RNA, and as probes for Z-DNA in genomes, the methods being highly selective
and sensitive.
Just as antibodies are available for particular proteins, antibodies against individual
mRNAs, tRNAs etc. would be of immense value. As the antigen binding sites of nucleic 
acid reactive antibodies span a stretch of 4–5 nucleotides it seems feasible to elicit 
antibodies against oligonucleotides of that size, but enough efforts have not been made
in this direction. If the oligonucleotides are chosen with proper planning it may be
possible to elicit antibodies specific to individual nucleic acids or to sequence specific
conformations of DNA. Thus there are exciting possibilities for the immediate future.
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